Member Info for Dibs61

Assume its been a 'getting your feet back under the desk' kind of week for him. Especially important if you've been off for medical reasons. Take it gradually, catch up with people, how the business is doing. I imagine strategic goals will emerge in the next few weeks.

I can dummy sell for 207.5 (above the quoted mid).

I find the SP action and movement on this stock baffling. No other share behaves quite like it. I know it’s illogical but I find it disconcerting because it is hard to fathom!

That said it’s a quality stock.

Although I would agree with others that there is no leak - I think within Synairgen themselves it’s a tight ship. However as this whole thing mushrooms more people are ‘in the know’ as there are more and more parties involved. It must become more difficult to keep a complete lid on things. FWIW yes it’s prob just the removal of a larger seller that’s allowed the price to rise back up.

Yes Bella is right it’s not ours. But that’s fine, it’s clear our inhalation delivery is more safely and directly targeted to the initial affected main organ ie.lung. Our time is coming soon, I’m sure of it,

In delayed 5 and 10k blocks.

Wouldn’t Peer review follow subsequent to the publication of the full dataset of Hospital results? I mean the great and the mighty wouldn’t have sight of it before it is made public? My point being we would get RNS of full dataset first then peer review?

I take the view that the data itself is far more important than what some professors who have no interest have to say about it, “Data is king”.

The data will endorse and confirm the companies headlines and this will cement the current valuation and you would hope give the SP a good bump upwards again. Doubt and caution will be removed and we can move on to the next step. I will be astonished if the company went it alone into Phase 3. I would be staggered as it would go against the stated strategy over the past few years. They are looking for a partner. Again, it would be immensely surprising if a partner did not want a stake at least by Phase 3 stage. Phase 3 I believe has to be international and focused on countries with a large number of cases. We all know who they are.

Exciting times indeed. And the last thing that would surprise me immensely is if we have much longer to find out the next steps! But let’s see that data. Let’s show the world how good it is..

IMHO ... lots of 5k and 10k block trades going through symptomatic of II stake building

Don’t forget this mornings RNS was the position on Wednesday. I suspect they have continued to accumulate since then hence the holding/dropping of SP to extract more stock for them

A good time for new entrants or top ups. I have no spare cash and am fully loaded waiting, like everyone else for news. NOT a good time to sell now imho

‘Punit’ Is a complete wind up. His posts are simply a reflection of how he is seeing the current market sentiment but entirely simplistic and deliberately coming across as naive though he is not naive. Often he is being tongue in cheek. Normally fishing for attention. You (and I on this occasion) are feeding him and getting the response his one line posts crave.

It’s simple really. Just ignore or filter if you don’t like it, personally it makes me chuckle.

Started early today! Wonder who’s accumulating now?

I can dummy buy for 217
Dummy sell for 217.5

Has the look of yet more order filling. Looking forward to the data publication now. It should be very good. What did RM say about it last week? "We couldn't have hoped for any better data". It surpassed their own expectations.

The positive data publication should eliminate a sticking point of doubt and caution put forward by many academics thus far. And give the market more confidence to continue the rerating of the stock.

To be fair hold4results it did sound very much from your previous post that you weren't holding for results! Which would be absolutely fair enough. But you and I know this is not like any of the other 'Covid' stocks.

I do not believe that Richard Marsden and Messrs Holgate and Wilkinson (with their considerable experience) would have released the RNS they did last week if the all important data was not as good has been indicated. The publication of the data and peer review is now key to the next step and I believe, based on the recent headline results that it will be more than sufficent to take us to the next step. This has already been substantially, albeit not fully derisked. The entry of Venrock last week after the results is, I would suggest, a positive affirmation.

Everything has a price Brentw1 ;) Whats yours?

This is what I have ascertained from my research in terms of what SNG will now seek to do.

Richard Marsden has previously made their strategy absolutely clear. They are all about licensing the product (SNG001) to a large Pharmaceutical partner who will take it to market (and, incidentally run the PIII trial IF required).

He has said they are all about getting the early stage clinical data (though successful completion of PII is not early stage imo) and then transacting with a large Pharma company. I do not believe they have any intention of running a PIII trial - if required.

So, it is either going to be a licensed partnership with either a single or multiple mega Pharmas OR they will receive an offer to acquire the company, or maybe it will become a bidding war.

I am now very confident about the data being as good as they say it will be and I also believe the COPD trial results next month are going to be excellent. That will send the SP into orbit if it has not already done so.

OK I know this is a big ramp but it is my absolute genuine belief and that is why I have now broken all the investing rules and gone all in on this one stock.

Sparkle - because have you are ever noticed there are multiple MMs for this stock. Each runs their own book. Orders will be specific to each MM. Only 1 MM needs to have a large order and that can hold the price at that level.

Alexmoneybags they will take my entire holding to for 218.25

They certainly do want our shares!

Sparkle you may not think its large orders but I can see there is no shortage of retail demand but this temporary 'drag' on the SP action is typical of large order filling. There are many many buys going through but not currently moving the price because of demand - supply. We can see the demand but the supply is 'hidden'. Thats why you can buy a lot of shares because the MM's currently have a lot to offload to balance out the equation. But look how the price is holding up. That is a strong indicator of the demand.

I agree it probably needs another positive RNS to take the next leg up OR it could be some other relevant news that leaks out such as a Trump move for the drug.

But IMO this is heading one way. UP.

Manifesto - cheers - I make you 100% correct. The results are as good as could possibly be expected. Not my word but the CEO's. He is NOT b*llsh*tting. This is a colossal opportunity staring investors straight in the face.

Doubt, scepticism and procrastination will not lose you anything. But it WILL stop you from taking this very very rare opportunity on the AIM market to clean up. Lifechanging stuff IMHO. I have done my research and I am convinced.

It is simply a question of when the end game will play out - not long IMO and just how much money will be made here. But it has the potential to be a huge gain and, indeed, already has been for myself and many otheres.

GLA and DYOR